We are live on
!
Find out more
P
Pitcairn Portfolio holdings
AUM
$1.27B
1-Year Est. Return
23.64%
This Fund
S&P 500
This Quarter
Est. Return
+4.52%
1 Year Est. Return
+23.64%
3 Year Est. Return
+111.21%
5 Year Est. Return
+126.49%
10 Year Est. Return
+390.83%
AUM
$833M
AUM Growth
+$7.36M
(+0.89%)
Cap. Flow
-$24.9M
Cap. Flow
% of AUM
-2.99%
Top 10 Holdings %
Top 10 Hldgs %
52.45%
Holding
520
New
34
Increased
100
Reduced
321
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$3.57M |
| 2 |
Intuit
INTU
|
+$2.04M |
| 3 |
Cadence Design Systems
CDNS
|
+$1.21M |
| 4 |
Gilead Sciences
GILD
|
+$1.12M |
| 5 |
Steel Dynamics
STLD
|
+$778K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$3.05M |
| 2 |
NXP Semiconductors
NXPI
|
+$2.76M |
| 3 |
Akamai
AKAM
|
+$1.93M |
| 4 |
TE Connectivity
TEL
|
+$1.92M |
| 5 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$1.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 24.59% |
| 2 | Financials | 10.12% |
| 3 | Technology | 8.57% |
| 4 | Healthcare | 7.38% |
| 5 | Consumer Discretionary | 5.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
iShares Russell 3000 ETF
IWV
$19.7B
| $159M | 19.13% |
1,106,295
+2,825
| +0.3% | +$402K |
|
2
Brown-Forman Class A
BF.A
$12.2B
| $141M | 16.96% |
3,581,121
| – | – |
|
|
3
Brown-Forman Class B
BF.B
$11.9B
| $36.1M | 4.33% |
1,159,180
-90
| -0% | -$2.82K |
|
4
iShares Russell 1000 ETF
IWB
$48.1B
| $25.6M | 3.07% |
189,236
-3,471
| -2% | -$463K |
|
5
iShares Russell 1000 Value ETF
IWD
$81.7B
| $20.2M | 2.43% |
173,632
-999
| -0.6% | -$115K |
|
6
Berkshire Hathaway Class A
BRK.A
$1.06T
| $14.5M | 1.74% |
57
| – | – |
|
7
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.73B
| $13.2M | 1.59% |
556,466
+19,097
| +4% | +$449K |
|
8
Amazon
AMZN
$2.7T
| $9.27M | 1.11% |
191,600
-9,920
| -5% | -$473K |
|
9
Meta Platforms (Facebook)
META
$1.64T
| $8.8M | 1.06% |
58,314
-67
| -0.1% | -$9.96K |
|
10
Vanguard Russell 3000 ETF
VTHR
$4.66B
| $8.52M | 1.02% |
76,488
-1,417
| -2% | -$156K |
|
11
Visa
V
$688B
| $8.03M | 0.96% |
85,593
-4,248
| -5% | -$394K |
|
12
Apple
AAPL
$4.78T
| $7.17M | 0.86% |
199,072
+6,184
| +3% | +$229K |
|
13
Vanguard Total Stock Market ETF
VTI
$660B
| $6.11M | 0.73% |
49,057
-22
| -0% | -$2.71K |
|
14
Adobe
ADBE
$91.6B
| $5.46M | 0.66% |
38,611
+3,498
| +10% | +$479K |
|
15
Alphabet (Google) Class A
GOOGL
$4.35T
| $5.33M | 0.64% |
114,600
-4,300
| -4% | -$201K |
|
16
Intuitive Surgical
ISRG
$123B
| $4.75M | 0.57% |
45,666
-81
| -0.2% | -$7.79K |
|
17
Johnson & Johnson
JNJ
$603B
| $4.75M | 0.57% |
35,879
-75
| -0.2% | -$9.57K |
|
|
18
Alphabet (Google) Class C
GOOG
$4.35T
| $4.68M | 0.56% |
103,080
-1,260
| -1% | -$57.7K |
|
19
JPMorgan Chase
JPM
$903B
| $4.57M | 0.55% |
50,043
+231
| +0.5% | +$19.9K |
|
20
Salesforce
CRM
$140B
| $4.39M | 0.53% |
50,747
-25
| -0% | -$2.18K |
|
21
Microsoft
MSFT
$2.95T
| $4.3M | 0.52% |
62,395
-1,216
| -2% | -$83.5K |
|
22
Danaher
DHR
$143B
| $4.19M | 0.5% |
56,065
+2,415
| +5% | +$181K |
|
23
Valero Energy
VLO
$92.8B
| $3.87M | 0.46% |
57,342
+5,458
| +11% | +$354K |
|
|
24
Zoetis
ZTS
$31.7B
| $3.77M | 0.45% |
+60,519
| New | +$3.57M |
|
25
PayPal
PYPL
$50.1B
| $3.61M | 0.43% |
67,232
+5,411
| +9% | +$266K |
|
Similar funds
SFI
WCWM
BA
SAM
4CM
SIMG
HT
BCM
Pitcairn's Q2 2017 Portfolio in Review
As of Q2 2017, Pitcairn held 520 positions worth $833M, up 0.89% from $825M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Pitcairn's Q2 2017 filing shows 34 new, 100 increased, 321 reduced and 48 closed positions. Its largest new stake was Zoetis: 60,519 shares worth $3.77M. The largest sale was LyondellBasell Industries, an estimated $3.05M.
By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, up from 24% a quarter earlier, followed by Financials and Technology.
- Pitcairn's largest Q2 2017 buy was Zoetis: 60,519 shares worth $3.77M.
- Pitcairn added most to Intuit in Q2 2017, an estimated $2.04M increase.
- Pitcairn's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $1.54M.
- Pitcairn fully exited LyondellBasell Industries in Q2 2017, selling an estimated $3.05M.
- Pitcairn's ten largest holdings make up 52% of its $833M portfolio in Q2 2017.
- Pitcairn opened 34 new positions and closed 48 in Q2 2017.
- Pitcairn's portfolio value rose 0.89% quarter-over-quarter to $833M.
Based on Pitcairn's 13F filing for Q2 2017, filed 2 Aug 2017.